Personalized Text Messages to Improve Antiretroviral Treatment (ART) Adherence in HIV+ Methamphetamine Users (iTAB)
|ClinicalTrials.gov Identifier: NCT01317277|
Recruitment Status : Completed
First Posted : March 17, 2011
Last Update Posted : June 26, 2014
|Condition or disease||Intervention/treatment|
|HIV AIDS||Behavioral: individualized Texting for Adherence Building (iTAB) Behavioral: Psychoeducation|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||75 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Health Services Research|
|Official Title:||Personalized Text Messages to Improve ART Adherence in HIV+ Methamphetamine Users|
|Study Start Date :||April 2011|
|Primary Completion Date :||June 2014|
|Study Completion Date :||June 2014|
Experimental: Texting + Psychoeducation
Participants in the individualized Texting for Adherence Building (iTAB) arm will receive daily text messaging reminders for antiretroviral medication adherence. These text messages will be targeted to the specific schedule and needs of the individual. Participants will also receive a one-time psychoeducational intervention reviewing the importance of adherence to anti-HIV medications.
Behavioral: individualized Texting for Adherence Building (iTAB)
Intervention is designed to send automated text messages to HIV+ persons who are current methamphetamine (METH+) users. Text messages are personalized, automated, real-time text messages. The iTAB intervention is designed to improve adherence to ART medications among HIV+/METH+ persons above and beyond an active comparator group.
Active Comparator: Psychoeducation
Participants will receive a one-time psychoeducational intervention reviewing the importance of adherence to anti-HIV medications. They will also receive daily text messages to evaluate mood and methamphetamine use, but these messages will not remind participants about medication adherence.
Participants will also receive daily text messages to evaluate mood and methamphetamine use, but these messages will not remind participants about medication adherence.
- Adherence to Antiretroviral Medication [ Time Frame: Completion of 6-week intervention ]Adherence will be measured using Medication Event Monitoring Systems (MEMS)
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01317277
|United States, California|
|San Diego, California, United States, 92013|
|Principal Investigator:||David J Moore, Ph.D.||University of California, San Diego|